Ditchcarbon
  • Contact
  1. Organizations
  2. Fresenius Kabi Pharmaceuticals Holding, Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
US
updated 21 days ago

Fresenius Kabi Pharmaceuticals Holding, Inc.

Company website

Fresenius Kabi Pharmaceuticals Holding, Inc., a prominent player in the global healthcare sector, is headquartered in the United States. Founded in 1996, the company has established itself as a leader in the pharmaceutical and medical device industries, focusing on lifesaving medicines and technologies. With a strong presence in North America, Europe, and Asia, Fresenius Kabi is dedicated to providing high-quality intravenous (IV) drugs, infusion therapies, and clinical nutrition products. The company is renowned for its commitment to innovation and quality, offering a diverse portfolio that includes generic injectable medications and specialty pharmaceuticals. Fresenius Kabi's unique approach to patient care and its robust supply chain have positioned it as a trusted partner in hospitals and healthcare facilities worldwide. Notable achievements include a strong market position in the parenteral nutrition segment, underscoring its role in enhancing patient outcomes across various therapeutic areas.

DitchCarbon Score

How does Fresenius Kabi Pharmaceuticals Holding, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

46

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Fresenius Kabi Pharmaceuticals Holding, Inc.'s score of 46 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

67%

Let us know if this data was useful to you

Fresenius Kabi Pharmaceuticals Holding, Inc.'s reported carbon emissions

Inherited from Fresenius SE & Co. KGaA

Fresenius Kabi Pharmaceuticals Holding, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Fresenius SE & Co. KGaA, which may influence its climate commitments and reporting practices. As part of its corporate family, any climate initiatives or targets may be inherited from Fresenius SE & Co. KGaA. However, there are no documented reduction targets or climate pledges available for Fresenius Kabi Pharmaceuticals Holding, Inc. at this time. The lack of specific emissions data and reduction initiatives suggests that the company may still be in the process of developing its climate strategy or reporting framework. In the broader context, companies in the pharmaceutical sector are increasingly focusing on sustainability and carbon reduction, often aligning with industry standards and frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). It remains essential for Fresenius Kabi Pharmaceuticals Holding, Inc. to establish clear climate commitments to enhance its sustainability profile and meet stakeholder expectations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
521,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
1,013,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Fresenius Kabi Pharmaceuticals Holding, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Fresenius Kabi Pharmaceuticals Holding, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Fresenius Kabi Pharmaceuticals Holding, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bd

US
•
Glass and glass products
Updated 4 days ago

Novartis Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

B. Braun Medical Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 24 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy